--- title: COVID-19 Resource Center description: As coronavirus continues to impact our way of life, it also impacts the IP landscape. Staying up-to-date on the latest deadlines, court changes and overall business impacts while managing your IP risks can feel overwhelming. The Wolf Greenfield team is here to help. This resource center includes: image: https://info.wolfgreenfield.com/hubfs/COVID.png --- # **COVID-19        ****RESOURCE CENTER** [![wg-logo-opt-1-white-1](https://info.wolfgreenfield.com/hs-fs/hubfs/wg-logo-opt-1-white-1.png?width=241&name=wg-logo-opt-1-white-1.png)](https://wolfgreenfield.com/)   # Intellectual Property & COVID-19 ## *Navigating The IP Landscape During Uncertain Times* As coronavirus continues to alter our way of life, it also impacts the IP landscape. Staying up-to-date on the latest deadlines, court changes and overall business climate while managing your IP risks can feel overwhelming. The Wolf Greenfield team is here to help. This resource center includes: - - [Key content from our team that is being regularly updated](https://info.wolfgreenfield.com/covid-19-resource-center#latest-from-WGS)   - [Uplifting news about our clients’ COVID-19 efforts](https://info.wolfgreenfield.com/covid-19-resource-center#clients-in-the-news) - [A message from our President and Managing Partner](https://info.wolfgreenfield.com/covid-19-resource-center#tim-oyer) - [A team of attorneys who are ready to help](https://info.wolfgreenfield.com/covid-19-resource-center#our-team) - [Additional outside resources that we find helpful](https://info.wolfgreenfield.com/covid-19-resource-center#additional-stuff) # Latest from Wolf Greenfield ## Alerts, Articles, Blogs & Podcasts ![](https://info.wolfgreenfield.com/hs-fs/hubfs/Article%20Columns.png?width=1024&height=512&name=Article%20Columns.png) #### A Precautionary Tale: District Courts Take Varying Measures As In-Person Trials Appear on the Horizon While the strain of the pandemic and its attendant restrictions are universally being felt within the court system, not all jurisdictions are alike when it comes to the precautions deemed necessary to proceed cautiously with in-person trials. [Read More](https://wolfgreenfield.com/publications/articles/2021/a-precautionary-tale-district-courts-take-varying-measures-as-in-person) ![Article Chairs ](https://info.wolfgreenfield.com/hs-fs/hubfs/Article%20Chairs%20.png?width=1024&height=512&name=Article%20Chairs%20.png) #### Many of Us Will Be Working From Home Forever Elizabeth Dornburgh was quoted by *Insider Pro* on working remotely during the pandemic. [Learn More](https://www.wolfgreenfield.com/news-and-events/news/2020/elizabeth-dornburgh-quoted-by-insider-pro-on-working-remotely#.YFOSv69KhnI) ![Article COVID 3](https://info.wolfgreenfield.com/hs-fs/hubfs/Article%20COVID%203.png?width=1024&height=512&name=Article%20COVID%203.png) #### COVID Prompts Compromise: Jury Trial Set to Proceed In-Person Partially Courts are grappling with the question of when to resume jury trials and how to keep the litigants, attorneys, witnesses, jurors and court staff safe once they do.  [Read More](https://www.wolfgreenfield.com/publications/articles/2020/covid-prompts-compromise-jury-trial-set-to-proceed-inperson-partially) ![Article Chairs ](https://info.wolfgreenfield.com/hs-fs/hubfs/Article%20Chairs%20.png?width=1024&height=512&name=Article%20Chairs%20.png) #### Remote Depositions During COVID-19 and Beyond While remote depositions are not a new aspect of litigators’ practice, the COVID-19 pandemic has forced many to adopt this previously underutilized aspect of discovery proceedings.  [Read More](https://www.wolfgreenfield.com/publications/articles/2020/remote-depositions-during-covid19-and-beyond) ![Article COVID 3](https://info.wolfgreenfield.com/hs-fs/hubfs/Article%20COVID%203.png?width=1024&height=512&name=Article%20COVID%203.png) #### The Impact of Foreign-Based Witnesses on COVID-Related Requests for Extensions Recent orders in the Eastern District of Texas demonstrate the potential impact of foreign discovery during the pandemic. [Read More](https://www.wolfgreenfield.com/publications/articles/2020/the-impact-of-foreign-based) ![Article Chairs ](https://info.wolfgreenfield.com/hs-fs/hubfs/Article%20Chairs%20.png?width=1024&height=512&name=Article%20Chairs%20.png) #### COVID-19: Impact on Patent Procedures The impact COVID-19 has had on patent procedures. Topics covered include impact on United States practice, impact on European practice, other jurisdictions and  takeaways. [Read More](https://www.wolfgreenfield.com/publications/articles/2020/covid19-impact-on-patent-procedures) ![Article COVID 3](https://info.wolfgreenfield.com/hs-fs/hubfs/Article%20COVID%203.png?width=1024&height=512&name=Article%20COVID%203.png) #### COVID-19 Prioritized Examination Pilot Program The USPTO announced a new program designed to prioritize examination of patents geared towards the prevention or treatment of COVID-19. [Read More](https://www.wolfgreenfield.com/publications/articles/2020/covid19-prioritized-examination-pilot-program) ![Article Chairs ](https://info.wolfgreenfield.com/hs-fs/hubfs/Article%20Chairs%20.png?width=1024&height=512&name=Article%20Chairs%20.png) #### Hearings in the Time of COVID-19: Effective Representation While Remote Effectively all hearings and oral arguments must be cancelled, rescheduled or conducted remotely. Here are insights gleaned from remote hearings. [Read More](https://www.wolfgreenfield.com/publications/articles/2020/hearings-in-the-time-of-corona) ![podcast](https://info.wolfgreenfield.com/hs-fs/hubfs/podcast.png?width=1024&height=512&name=podcast.png) #### American Bar Association’s Legal Rebels Podcast John Van Amsterdam was featured on the ABA’s Legal Rebels Podcast to discuss virtual hiring and onboarding during COVID-19 as well as ways in which he’s connecting with clients. [Listen Here](https://wolfgreenfield.com/news-and-events/news/2021/john-van-amsterdam-featured-on-american-bar-association-legal-rebels-podcast#.YFOTMa9KhnJ) ![Alert Arch with People ](https://info.wolfgreenfield.com/hs-fs/hubfs/Alert%20Arch%20with%20People%20.png?width=1024&height=512&name=Alert%20Arch%20with%20People%20.png) #### IP Litigation Timing Considerations in Light of COVID-19 Parties to pending or future IP litigation should consider the effects of COVID-19 related restrictions and measures when developing a strategy for moving cases forward.  [Read More](https://www.wolfgreenfield.com/publications/ip-alerts/2020/ip-litigation-timing-considerations-in-light-of-covid19) ![Article Swirl Staircase](https://info.wolfgreenfield.com/hs-fs/hubfs/Article%20Swirl%20Staircase.png?width=1024&height=512&name=Article%20Swirl%20Staircase.png) #### How Five IP Lawyers Adapted to New Jobs During COVID Tonia Sayour was quoted by* Managing IP* on adapting to a new job during COVID. [Read More](https://www.wolfgreenfield.com/news-and-events/news/2020/tonia-sayour-quoted-by-managing-ip-on-adapting-to-a-new-job-during-covid#.YFOSZa9KhnI) ![Article COVID 1](https://info.wolfgreenfield.com/hs-fs/hubfs/Article%20COVID%201.png?width=1024&height=512&name=Article%20COVID%201.png) #### One Size Does Not Fit All: ##### Courts Exercise Discretion in Addressing the Need for Remote Depositions in the Wake of COVID-19 Courts across the country are responding by modifying their standard procedures. [Read More](https://www.wolfgreenfield.com/publications/articles/2020/one-size-does-not-fit-all-courts-exercise-discretion-in-addressing-the-need-for-remote-depositions) ![Article Swirl Staircase](https://info.wolfgreenfield.com/hs-fs/hubfs/Article%20Swirl%20Staircase.png?width=1024&height=512&name=Article%20Swirl%20Staircase.png) #### Pandemic Collaborations Pose Risk Of Future Patent Disputes Dan Young was quoted by *Law360* on the importance of taking a step back to make sure key IP issues are being addressed when forming COVID-19 collaborations. [Read More](https://www.wolfgreenfield.com/news-and-events/news/2020/dan-young-quoted-by-law360#.Xt_JWkVKhnI) ![Article COVID 1](https://info.wolfgreenfield.com/hs-fs/hubfs/Article%20COVID%201.png?width=1024&height=512&name=Article%20COVID%201.png) #### Must the Show Go On? Some Judges Press Forward Scheduling Remote Patent Bench Trials Two recent decisions indicate the judiciary’s willingness and desire to move patent cases along. [Read More](https://www.wolfgreenfield.com/publications/articles/2020/must-the-show-go-on) ![Blog Swirly Staircase](https://info.wolfgreenfield.com/hs-fs/hubfs/Blog%20Swirly%20Staircase.png?width=1024&height=512&name=Blog%20Swirly%20Staircase.png) #### Appearing Before PTAB During COVID-19: What You Need to Know Important changes practitioners should know regarding case management, CARES Act extensions and remote hearings at the PTAB. [Read More](https://blog.wolfgreenfield.com/postgrant/appearing-before-ptab-during-covid-19-what-you-need-to-know) ![Article COVID 1](https://info.wolfgreenfield.com/hs-fs/hubfs/Article%20COVID%201.png?width=1024&height=512&name=Article%20COVID%201.png) #### Serving Notice While Six Feet Apart: Substituted Service in Light of COVID-19 This article explains what litigants on both sides of the “v.” need to know about service during the pandemic.    [Read More](https://www.wolfgreenfield.com/publications/articles/2020/serving-notice-while-six-feet-apart) ![Article Columns](https://info.wolfgreenfield.com/hs-fs/hubfs/Article%20Columns.png?width=1024&height=512&name=Article%20Columns.png) #### What Civil Jury Trials Might Look Like In The Time of COVID While all jury trials for civil cases are currently still on hold in the District of Massachusetts, learn what civil jury trials may look like when they are eventually conducted. [Read More](https://www.wolfgreenfield.com/publications/articles/2020/what-civil-jury-trials-might-look-like-in-the-time-of-covid19) ![Article COVID 2](https://info.wolfgreenfield.com/hs-fs/hubfs/Article%20COVID%202.png?width=1024&height=512&name=Article%20COVID%202.png) #### Lawyers Ponder Impact of COVID Cocktail Lawsuit Chelsea Loughran was quoted by *Managing IP* on the impact of COVID-related patent lawsuits. [Read More](https://www.wolfgreenfield.com/news-and-events/news/2020/chelsea-loughran-quoted-by-managing-ip-on-impact-of-recent-covidrelated-patent-lawsuits#.YFORXa9KhnI) ![Article Columns](https://info.wolfgreenfield.com/hs-fs/hubfs/Article%20Columns.png?width=1024&height=512&name=Article%20Columns.png) #### Impact and 'Unintended Benefits' of the Federal Circuit's Suspension of In-Person Oral Arguments This article on the Federal Circuit by Greg Corbett and Marie McKiernan was published in *Law.com.             * [Read More](https://www.wolfgreenfield.com/publications/articles/2020/impact-and-unintended-benefits) ![Blog Stairs Blue](https://info.wolfgreenfield.com/hs-fs/hubfs/Blog%20Stairs%20Blue.png?width=1024&height=512&name=Blog%20Stairs%20Blue.png) #### COVID-19 Changes How Some Courts Consider Motions to Stay Pending IPR In some instances, courts shifting resources to address COVID-19-related concerns is changing how courts evaluate motions to stay pending IPR. [Read More](https://blog.wolfgreenfield.com/postgrant/covid-19-changes-how-some-courts-consider-motions-to-stay-pending-ipr) ![LitAlert](https://info.wolfgreenfield.com/hs-fs/hubfs/LitAlert.png?width=1024&height=512&name=LitAlert.png) #### IP Deadline Extensions Across The Globe Due to COVID-19 In this alert, we present a snapshot summary of actions taken by various IP offices with respect to extensions of deadlines and payment of fees due COVID-19. [Read More](https://www.wolfgreenfield.com/publications/ip-alerts/2020/ip-deadline-extensions-across-the-globe) ![Article COVID 2](https://info.wolfgreenfield.com/hs-fs/hubfs/Article%20COVID%202.png?width=1024&height=512&name=Article%20COVID%202.png) #### WIPO Launches COVID-19 IP Policy Tracker The World Intellectual Property Organization has launched the COVID-19 IP Policy Tracker, a tool that provides information on pandemic-related intellectual property office policy changes. [Read More](https://www.wolfgreenfield.com/publications/articles/2020/world-intellectual-property-organization-launches-covid19-ip-policy-tracker) ![Article Columns](https://info.wolfgreenfield.com/hs-fs/hubfs/Article%20Columns.png?width=1024&height=512&name=Article%20Columns.png) #### The Open COVID Pledge: What You Need to Know Some organizations and institutions are pledging to make their intellectual property freely available to end the COVID-19 pandemic. This article discusses "The Open COVID Pledge." [Read More](https://www.wolfgreenfield.com/publications/articles/2020/the-open-covid-pledge) # **Clients in the News** ##### Our firm is lucky enough to work with clients that are making a difference in combatting COVID-19. Here are some of their interesting and impactful efforts. [![Amgen-Logo-PNG-Transparent](https://info.wolfgreenfield.com/hs-fs/hubfs/Amgen-Logo-PNG-Transparent.png?width=2088&name=Amgen-Logo-PNG-Transparent.png) ](https://info.wolfgreenfield.com/covid-19-resource-center#team-member1) ![Amgen-Logo-PNG-Transparent](https://info.wolfgreenfield.com/hs-fs/hubfs/Amgen-Logo-PNG-Transparent.png?width=2088&height=576&name=Amgen-Logo-PNG-Transparent.png) **Amgen **and the Amgen Foundation have committed up to $12.5 million to support COVID-19 relief efforts. [Read More](https://wwwext.amgen.com/media/news-releases/2020/03/amgen-and-the-amgen-foundation-commit-up-to-$12-5-million-to-support-covid-19-relief-efforts/)   [![analog-devices-01-logo-png-transparent](https://info.wolfgreenfield.com/hs-fs/hubfs/analog-devices-01-logo-png-transparent.png?width=557&name=analog-devices-01-logo-png-transparent.png) ](https://info.wolfgreenfield.com/covid-19-resource-center#team-member2) ![analog-devices-01-logo-png-transparent](https://info.wolfgreenfield.com/hs-fs/hubfs/analog-devices-01-logo-png-transparent.png?width=557&height=164&name=analog-devices-01-logo-png-transparent.png) The **Analog Devices** Foundation donated $500,000 to Massachusetts General Hospital’s Vaccine & Immunotherapy Center to advance COVID-19 vaccine development. [Read More](https://www.businesswire.com/news/home/20200420005190/en/Analog-Devices-Foundation-Donates-500000-Massachusetts-General?mc_cid=e960765d3d&mc_eid=3a74e514c5)     [![Becton_Dickinson_Logo_old-1](https://info.wolfgreenfield.com/hs-fs/hubfs/Becton_Dickinson_Logo_old-1.png?width=200&name=Becton_Dickinson_Logo_old-1.png) ](https://info.wolfgreenfield.com/covid-19-resource-center#team-member3) ![Becton_Dickinson_Logo_old-1](https://info.wolfgreenfield.com/hs-fs/hubfs/Becton_Dickinson_Logo_old-1.png?width=200&height=76&name=Becton_Dickinson_Logo_old-1.png) **Beckton Dickinson **is seeking emergency US approval to ramp up coronavirus tests.  [Read More](https://www.forbes.com/sites/brucejapsen/2020/03/17/becton-dickinson-seeks-emergency-fda-request-to-ramp-up--coronavirus-tests/#7cd4dafc31ca) [![BioAegis_Basics_white_therapeutics_scaled](https://info.wolfgreenfield.com/hs-fs/hubfs/BioAegis_Basics_white_therapeutics_scaled.png?width=366&name=BioAegis_Basics_white_therapeutics_scaled.png) ](https://info.wolfgreenfield.com/covid-19-resource-center#team-member4) ![BioAegis_Basics_white_therapeutics_scaled](https://info.wolfgreenfield.com/hs-fs/hubfs/BioAegis_Basics_white_therapeutics_scaled.png?width=366&height=184&name=BioAegis_Basics_white_therapeutics_scaled.png) **BioAegis** is developing rhu-pGSN (recombinant human plasma gelsolin) based on a patent portfolio licensed from The Brigham and Women’s Hospital. [Read More](https://www.cnbc.com/2020/05/11/bioaegis-says-its-inflammation-regulator-best-weapon-against-covid-19.html)   [![Boehringer_Ingelheim_Logo.svg](https://info.wolfgreenfield.com/hs-fs/hubfs/Boehringer_Ingelheim_Logo.svg.png?width=496&name=Boehringer_Ingelheim_Logo.svg.png) ](https://info.wolfgreenfield.com/covid-19-resource-center#team-member5) ![Boehringer_Ingelheim_Logo.svg](https://info.wolfgreenfield.com/hs-fs/hubfs/Boehringer_Ingelheim_Logo.svg.png?width=496&height=164&name=Boehringer_Ingelheim_Logo.svg.png) **Boehringer Ingelheim** donated $1 million in goods to the China Red Cross Foundation and is investigating antiviral compounds from past research against SARS-CoV2.  [Read More](https://www.boehringer-ingelheim.com/covid-19/fighting-covid-19?itid=Fighting%20COVID-19) [![Boston_Childrens_Hospital_logo](https://info.wolfgreenfield.com/hs-fs/hubfs/Boston_Childrens_Hospital_logo.png?width=2500&name=Boston_Childrens_Hospital_logo.png) ](https://info.wolfgreenfield.com/covid-19-resource-center#team-member6) ![Boston_Childrens_Hospital_logo](https://info.wolfgreenfield.com/hs-fs/hubfs/Boston_Childrens_Hospital_logo.png?width=2500&height=1287&name=Boston_Childrens_Hospital_logo.png) Ofer Levy of **Boston Children’s Hospital** was interviewed by CNN about COVID-19. [Watch here](https://app.frame.io/reviews/75ac1cf0-2dc3-4953-a28b-00ad4616f14b/29712304-a19c-40d1-a275-d64f80b79ff1).   [![download-3](https://info.wolfgreenfield.com/hs-fs/hubfs/download-3.png?width=442&name=download-3.png) ](https://info.wolfgreenfield.com/covid-19-resource-center#team-member7) ![download-3](https://info.wolfgreenfield.com/hs-fs/hubfs/download-3.png?width=442&height=114&name=download-3.png) Robots from **Boston Dynamics** are being used as a “mobile telemedicine platform” to minimize hospital staffs' exposure to COVID-19. [Read More](https://www.boston.com/news/coronavirus/2020/04/23/boston-dynamics-coronavirus) Their robots are also being used in Singapore to encourage social distancing. [Read More](https://www.cnn.com/2020/05/08/tech/singapore-coronavirus-social-distancing-robot-intl-hnk/index.html?utm_medium=social&utm_content=2020-05-12T02%3A04%3A41&utm_source=twCNN&utm_term=video) [![Boxed.Logo.Green.RGB](https://info.wolfgreenfield.com/hs-fs/hubfs/Boxed.Logo.Green.RGB.png?width=5140&name=Boxed.Logo.Green.RGB.png) ](https://info.wolfgreenfield.com/covid-19-resource-center#team-member8) ![Boxed.Logo.Green.RGB](https://info.wolfgreenfield.com/hs-fs/hubfs/Boxed.Logo.Green.RGB.png?width=5140&height=995&name=Boxed.Logo.Green.RGB.png) Grocery delivery startup **Boxed** sees soaring demand amid pandemic. The company is prioritizing first responders’ orders.  [Learn More](https://www.cbsnews.com/video/grocery-delivery-start-up-boxed-sees-soaring-demand-amid-pandemic/) [![BroadInstLogoforDigitalRGB](https://info.wolfgreenfield.com/hs-fs/hubfs/BroadInstLogoforDigitalRGB.png?width=649&name=BroadInstLogoforDigitalRGB.png) ](https://info.wolfgreenfield.com/covid-19-resource-center#team-member9) ![BroadInstLogoforDigitalRGB](https://info.wolfgreenfield.com/hs-fs/hubfs/BroadInstLogoforDigitalRGB.png?width=649&height=164&name=BroadInstLogoforDigitalRGB.png) The **Broad Institute** is contributing to Massachusetts’s COVID-19 diagnostic testing, developing new diagnostic technologies and data analysis tools, and generating new biological insights.  [Read More](https://www.broadinstitute.org/news/how-broad-institute-helping-understand-and-overcome-covid-19) [![ButterflyNetworks](https://info.wolfgreenfield.com/hs-fs/hubfs/ButterflyNetworks.png?width=809&name=ButterflyNetworks.png) ](https://info.wolfgreenfield.com/covid-19-resource-center#team-member10) ![ButterflyNetworks](https://info.wolfgreenfield.com/hs-fs/hubfs/ButterflyNetworks.png?width=809&height=164&name=ButterflyNetworks.png) **Butterfly Network’s** portable ultrasound can image lungs or hearts hurt from coronavirus and hopes to lessen the stress on the health care system.  [Learn More](https://video.foxbusiness.com/v/6145994911001/#sp=news-clips) [![comrad](https://info.wolfgreenfield.com/hs-fs/hubfs/comrad.png?width=1265&name=comrad.png) ](https://info.wolfgreenfield.com/covid-19-resource-center#team-member11) ![comrad](https://info.wolfgreenfield.com/hs-fs/hubfs/comrad.png?width=1265&height=164&name=comrad.png) **Comrad **has donated over $30,000 worth of compression socks to nurses and doctors at the front line and they are accepting donations to provide more. [Read More](https://www.comradsocks.com/collections/support-health-heroes)     [![DFCI](https://info.wolfgreenfield.com/hs-fs/hubfs/DFCI.png?width=630&name=DFCI.png) ](https://info.wolfgreenfield.com/covid-19-resource-center#team-member12) ![DFCI](https://info.wolfgreenfield.com/hs-fs/hubfs/DFCI.png?width=630&height=155&name=DFCI.png) **Dana-Farber Cancer Institute** began running low on critical PPE and researchers found a solution. [Read More](https://www.bizjournals.com/boston/news/2020/04/22/dana-farber-started-running-low-on-ppe-then-it-had.html)     [![deka-logo-1](https://info.wolfgreenfield.com/hs-fs/hubfs/deka-logo-1.png?width=635&name=deka-logo-1.png) ](https://info.wolfgreenfield.com/covid-19-resource-center#team-member13) ![deka-logo-1](https://info.wolfgreenfield.com/hs-fs/hubfs/deka-logo-1.png?width=635&height=164&name=deka-logo-1.png) Dean Kamen of** DEKA **helped secure a shipment of protective equipment from China for New Hampshire. [Read More](https://edition.pagesuite.com/popovers/dynamic_article_popover.aspx?artguid=cfc92501-b6a3-456f-bc55-2828b3437396&appid=1165)     [![1200px-FLIR_logo.svg](https://info.wolfgreenfield.com/hs-fs/hubfs/1200px-FLIR_logo.svg.png?width=1200&name=1200px-FLIR_logo.svg.png) ](https://info.wolfgreenfield.com/covid-19-resource-center#team-member14) ![1200px-FLIR_logo.svg](https://info.wolfgreenfield.com/hs-fs/hubfs/1200px-FLIR_logo.svg.png?width=1200&height=400&name=1200px-FLIR_logo.svg.png) **FLIR Systems** was quoted in an article about how thermal imaging cameras are the latest devices businesses hope will help reopen the economy. [Read More](https://www.cbsnews.com/news/thermal-imaging-cameras-coronavirus/)   [![Formlabs_logo](https://info.wolfgreenfield.com/hs-fs/hubfs/Formlabs_logo.png?width=1130&name=Formlabs_logo.png) ](https://info.wolfgreenfield.com/covid-19-resource-center#team-member15) ![Formlabs_logo](https://info.wolfgreenfield.com/hs-fs/hubfs/Formlabs_logo.png?width=1130&height=164&name=Formlabs_logo.png) **Formlabs**, University of South Florida Health, Northwell Health and Tampa General Hospital joined forces to create 3D printed nasal swabs to test for COVID-19 in patients in emergency shortage situations.  [Read More](https://www.prnewswire.com/news-releases/university-of-south-florida-health-northwell-health-formlabs-and-tampa-general-hospital-join-forces-to-create-3d-printed-nasal-swabs-to-test-for-covid-19-in-patients-in-emergency-shortage-situations-301031338.html?mc_cid=d1dc5eece9&mc_eid=3a74e514c5) In addition, the FDA granted **Formlabs** emergency clearance for 3D-printed ventilator component. [Read More](https://www.zdnet.com/article/fda-grants-formlabs-emergency-clearance-for-3d-printed-ventilator-component/) [![ginkgo](https://info.wolfgreenfield.com/hs-fs/hubfs/ginkgo.png?width=1173&name=ginkgo.png) ](https://info.wolfgreenfield.com/covid-19-resource-center#team-member16) ![ginkgo](https://info.wolfgreenfield.com/hs-fs/hubfs/ginkgo.png?width=1173&height=164&name=ginkgo.png) **Ginkgo **commits $25 million of free access to platform for partner COVID-19 projects.  [Read More](https://www.ginkgobioworks.com/2020/03/17/ginkgo-commits-25m-of-free-access-to-our-platform-for-partner-covid-19-projects/) [![logo@2x](https://info.wolfgreenfield.com/hs-fs/hubfs/logo@2x.png?width=560&name=logo@2x.png) ](https://info.wolfgreenfield.com/covid-19-resource-center#team-member17) ![logo@2x](https://info.wolfgreenfield.com/hs-fs/hubfs/logo@2x.png?width=560&height=110&name=logo@2x.png) **GreenLight Biosciences** is expanding their vaccine efforts to establish a scalable current Good Manufacturing Practices (cGMP) manufacturing platform to allow for the production of almost any RNA-based COVID-19 vaccine at a scale and cost that enables global delivery. In addition, they are advancing a number of RNA-based vaccines and therapeutics against COVID-19. [Read More](https://www.americaninno.com/boston/funding-boston/greenlight-biosciences-raises-17m-to-scale-coronavirus-vaccine-development/?mc_cid=f6a5a78899&mc_eid=3a74e514c5)   [![jackson_laboratory](https://info.wolfgreenfield.com/hs-fs/hubfs/jackson_laboratory.png?width=622&name=jackson_laboratory.png) ](https://info.wolfgreenfield.com/covid-19-resource-center#team-member18) ![jackson_laboratory](https://info.wolfgreenfield.com/hs-fs/hubfs/jackson_laboratory.png?width=622&height=162&name=jackson_laboratory.png) **The Jackson Laboratory (JAX) **began providing coronavirus testing for CT residents. [Read More](https://www.wtnh.com/news/health/coronavirus/farmington-lab-to-begin-providing-coronavirus-testing-for-ct-residents/) **JAX** has also been working with researchers to reduce the long-term impact of the COVID-19 closings and to get them on track to return to normal once restrictions are lifted. [Read More](https://www.jax.org/news-and-insights/2020/april/getting-research-back-on-track)   [![Rothberg Logo](https://info.wolfgreenfield.com/hs-fs/hubfs/Rothberg%20Logo.png?width=425&name=Rothberg%20Logo.png) ](https://info.wolfgreenfield.com/covid-19-resource-center#team-member19) ![Rothberg Logo](https://info.wolfgreenfield.com/hs-fs/hubfs/Rothberg%20Logo.png?width=425&height=73&name=Rothberg%20Logo.png) Biotech entrepreneur **Jonathan Rothberg** is developing a rapid COVID-19 home test kit that could return results to your smartphone in a half hour. [Read More](https://robbreport.com/motors/marine/this-superyacht-owner-and-scientist-is-developing-a-30-minute-covid-19-home-test-kit-2906705/) MIT Technology Review also featured Rothberg's efforts.  [Read More](https://www.technologyreview.com/2020/04/16/999887/how-to-test-everyone-for-the-coronavirus/)  [![judy](https://info.wolfgreenfield.com/hs-fs/hubfs/judy.jpg?width=266&name=judy.jpg) ](https://info.wolfgreenfield.com/covid-19-resource-center#team-member20) ![judy](https://info.wolfgreenfield.com/hs-fs/hubfs/judy.jpg?width=266&height=83&name=judy.jpg) **Judy**, an in-case-of-emergency kit startup that is promising to be “ready for anything,” is working with experts to create curated disaster boxes based on where people live.  [Read More](https://www.forbes.com/sites/viviennedecker/2020/01/29/are-you-prepared-for-an-emergency-meet-judy/#6efce88d700c) [![jil](https://info.wolfgreenfield.com/hs-fs/hubfs/jil.png?width=183&name=jil.png) ](https://info.wolfgreenfield.com/covid-19-resource-center#team-member21) ![jil](https://info.wolfgreenfield.com/hs-fs/hubfs/jil.png?width=183&height=100&name=jil.png) **Eli Lilly and Co.** reached an agreement with the National Institutes of Health to study one of its drugs as a COVID-19 treatment. The drug is approved in more than 65 countries as a treatment for adults with moderately to severely active rheumatoid arthritis.  [Read More](https://www.marketwatch.com/story/eli-lilly-to-study-use-of-arthritis-drug-to-treat-covid-19-2020-04-10) They also opened labs and planned drive-thrus to help boost Indiana's COVID-19 testing capacity. [Read More](https://www.fiercebiotech.com/medtech/eli-lilly-opens-labs-plans-drive-thrus-to-help-boost-indiana-s-covid-19-testing-capacity) [![Kaleido-Blue-Transparent](https://info.wolfgreenfield.com/hs-fs/hubfs/Kaleido-Blue-Transparent.png?width=1925&name=Kaleido-Blue-Transparent.png) ](https://info.wolfgreenfield.com/covid-19-resource-center#team-member22) ![Kaleido-Blue-Transparent](https://info.wolfgreenfield.com/hs-fs/hubfs/Kaleido-Blue-Transparent.png?width=1925&height=526&name=Kaleido-Blue-Transparent.png) **Kaleido Biosciences** has initiated a controlled clinical study of Microbiome Metabolic Therapy KB109 in outpatients with mild-to-moderate COVID-19. [Read More](https://investors.kaleido.com/news-releases/news-release-details/kaleido-biosciences-initiates-controlled-clinical-study) Since then, **Kaleido Biosciences** has initiated a controlled clinical study with Mass General Hospital of Microbiome Metabolic Therapy KB109 in outpatients with mild-to-moderate COVID-19. [Read More](https://investors.kaleido.com/news-releases/news-release-details/kaleido-biosciences-initiates-controlled-clinical-study-0) [![Maverik-Brand-Logo-SVG-1](https://info.wolfgreenfield.com/hs-fs/hubfs/Maverik-Brand-Logo-SVG-1.png?width=905&name=Maverik-Brand-Logo-SVG-1.png) ](https://info.wolfgreenfield.com/covid-19-resource-center#team-member23) ![Maverik-Brand-Logo-SVG-1](https://info.wolfgreenfield.com/hs-fs/hubfs/Maverik-Brand-Logo-SVG-1.png?width=905&height=164&name=Maverik-Brand-Logo-SVG-1.png) **Maverik Lacrosse** shifts from helmets to making face shields for healthcare workers.  [Read More](https://www.localsyr.com/news/local-news/cascade-maverik-lacrosse-shifts-from-helmets-to-making-face-shields-for-healthcare-workers/)   [![mit-logo-png-2](https://info.wolfgreenfield.com/hs-fs/hubfs/mit-logo-png-2.png?width=793&name=mit-logo-png-2.png) ](https://info.wolfgreenfield.com/covid-19-resource-center#team-member24) ![mit-logo-png-2](https://info.wolfgreenfield.com/hs-fs/hubfs/mit-logo-png-2.png?width=793&height=244&name=mit-logo-png-2.png) A group at** MIT **figured out how to make an emergency ventilator for $100 using a common hospital item—instead of the usual $30,000**. ** [Read More](https://www.businessinsider.com/mit-emergency-ventilator-cheaper-design-plans-2020-3)   [![moderna height](https://info.wolfgreenfield.com/hs-fs/hubfs/moderna%20height.png?width=500&name=moderna%20height.png) ](https://info.wolfgreenfield.com/covid-19-resource-center#team-member25) ![moderna height](https://info.wolfgreenfield.com/hs-fs/hubfs/moderna%20height.png?width=500&height=164&name=moderna%20height.png) After starting human trials for a COVID-19 vaccine, **Moderna** was featured on 60 minutes.  [Read More](https://www.cbsnews.com/news/scientists-rush-to-develop-novel-coronavirus-vaccine-60-minutes-2020-03-22/) Since then, their potential coronavirus vaccine got $483 million boost from Feds. [Read More](https://boston.cbslocal.com/2020/04/17/coronavirus-vaccine-covid-19-funding-moderna-therapeutics-cambridge-massachusetts/) **Moderna** announced positive interim Phase 1 data for its mRNA vaccine (mRNA-1273) against novel coronavirus. [Read More](https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-positive-interim-phase-1-data-its-mrna-vaccine) **Moderna**, the first company to start US clinical trials of a Covid-19 vaccine, finished enrolling all 30,000 of its participants. [Read More ](https://www.cnn.com/2020/10/22/health/moderna-covid-19-vaccine-trial-30000-participants/index.html) Early data shows **Moderna's** coronavirus vaccine is 94.5% effective.  [Read More ](https://www.nytimes.com/2020/11/16/health/Covid-moderna-vaccine.html) **Moderna **intends to apply to the US Food and Drug Administration for authorization of its Covid-19 vaccine. [Read More ](https://www.cnn.com/2020/11/30/health/moderna-vaccine-fda-eua-application/index.html) [![nobull-coupons](https://info.wolfgreenfield.com/hs-fs/hubfs/nobull-coupons.png?width=492&name=nobull-coupons.png) ](https://info.wolfgreenfield.com/covid-19-resource-center#team-member26) ![nobull-coupons](https://info.wolfgreenfield.com/hs-fs/hubfs/nobull-coupons.png?width=492&height=164&name=nobull-coupons.png) **NOBULL **is donating thousands of CDC recommended face masks to medical professionals. They were able to access the masks from an FDA registered factory through their partners. They are accepting donations to procure face masks or other PPE for medical professionals.  [Read More](https://www.nobullproject.com/pages/working-hard-to-give-back)     [![NEW](https://info.wolfgreenfield.com/hs-fs/hubfs/NEW.png?width=200&name=NEW.png) ](https://info.wolfgreenfield.com/covid-19-resource-center#team-member27) ![NEW](https://info.wolfgreenfield.com/hs-fs/hubfs/NEW.png?width=200&height=127&name=NEW.png) **Nuance Communications** announced the Nuance Dragon Ambient eXperience solution for telehealth providers. [Read More](https://www.prnewswire.com/news-releases/nuance-launches-dragon-ambient-experience-for-telehealth-compatible-with-any-telehealth-platform-301043182.html?mc_cid=e960765d3d&mc_eid=3a74e514c5)     [![opko-diagnostics-1-1](https://info.wolfgreenfield.com/hs-fs/hubfs/opko-diagnostics-1-1.png?width=400&name=opko-diagnostics-1-1.png) ](https://info.wolfgreenfield.com/covid-19-resource-center#team-member28) ![opko-diagnostics-1-1](https://info.wolfgreenfield.com/hs-fs/hubfs/opko-diagnostics-1-1.png?width=400&height=164&name=opko-diagnostics-1-1.png) BioReference Laboratories, Inc., an **OPKO Health **company (NASDAQ: OPK), will accept an Indefinite Delivery Indefinite Quantity (IDIQ) contract award to provide Commercial Surge Capacity Testing for COVID-19 Emergency Response to the Centers for Disease Control and Prevention (CDC). [Read more](https://www.opko.com/news-media/press-releases/detail/399/opko-healths-bioreference-laboratories-awarded-commercial)     [![persivia-logo-1](https://info.wolfgreenfield.com/hs-fs/hubfs/persivia-logo-1.png?width=857&name=persivia-logo-1.png) ](https://info.wolfgreenfield.com/covid-19-resource-center#team-member29) ![persivia-logo-1](https://info.wolfgreenfield.com/hs-fs/hubfs/persivia-logo-1.png?width=857&height=164&name=persivia-logo-1.png) **Persivia** releases AI-driven ruleset to detect COVID-19 novel coronavirus in patients.  [Read More](https://finance.yahoo.com/news/persivia-releases-ai-driven-ruleset-130000204.html)     [![pluristem-1](https://info.wolfgreenfield.com/hs-fs/hubfs/pluristem-1.png?width=170&name=pluristem-1.png) ](https://info.wolfgreenfield.com/covid-19-resource-center#team-member30) ![pluristem-1](https://info.wolfgreenfield.com/hs-fs/hubfs/pluristem-1.png?width=170&height=112&name=pluristem-1.png) Position **Pluristem Therapeutics Inc. (PSTI)** announced  it has treated its first patient suffering from COVID-19 under the FDA Single Patient Expanded Access Program. [Read More](https://www.nasdaq.com/articles/pluristem-therapeutics-treats-first-covid-19-patient-in-u.s.-2020-04-13) [![1200px-Pfizer_logo.svg-1](https://info.wolfgreenfield.com/hs-fs/hubfs/1200px-Pfizer_logo.svg-1.png?width=150&name=1200px-Pfizer_logo.svg-1.png) ](https://info.wolfgreenfield.com/covid-19-resource-center#team-member31) ![1200px-Pfizer_logo.svg-1](https://info.wolfgreenfield.com/hs-fs/hubfs/1200px-Pfizer_logo.svg-1.png?width=150&height=94&name=1200px-Pfizer_logo.svg-1.png) **Pfizer **and BioNTech are co-developing a potential COVID-19 vaccine.  [Read More](https://www.pfizer.com/news/press-release/press-release-detail/pfizer_and_biontech_to_co_develop_potential_covid_19_vaccine)  **Pfizer** and the Pfizer Foundation have also announced the commitment of $40 million in medical and charitable cash grants to help combat the global health effects of the COVID-19 pandemic in the US and around the world.  [Read More](https://www.biospace.com/article/releases/pfizer-and-the-pfizer-foundation-donate-40-million-in-charitable-grants-expand-product-access-and-mobilize-colleagues-to-combat-covid-19-pandemic/) [![g3fufk2akxzbwaz5jdgn](https://info.wolfgreenfield.com/hs-fs/hubfs/g3fufk2akxzbwaz5jdgn.png?width=120&name=g3fufk2akxzbwaz5jdgn.png) ](https://info.wolfgreenfield.com/covid-19-resource-center#team-member32) ![g3fufk2akxzbwaz5jdgn](https://info.wolfgreenfield.com/hs-fs/hubfs/g3fufk2akxzbwaz5jdgn.png?width=120&height=120&name=g3fufk2akxzbwaz5jdgn.png) **PixMob** is developing solutions that benefit frontline workers during the pandemic. [Read More](https://www.pixmobcrisissolutions.com/)   [![Quanterix-Logo](https://info.wolfgreenfield.com/hs-fs/hubfs/Quanterix-Logo.png?width=750&name=Quanterix-Logo.png) ](https://info.wolfgreenfield.com/covid-19-resource-center#team-member33) ![Quanterix-Logo](https://info.wolfgreenfield.com/hs-fs/hubfs/Quanterix-Logo.png?width=750&height=202&name=Quanterix-Logo.png) Researchers across the globe are deploying **Quanterix Corporation’s** Simoa® technology to profile innate immune response in COVID-19 patients, with the aim of identifying indicators associated with poor outcomes and opening new avenues for targeted therapies. [Read more](https://www.businesswire.com/news/home/20200720005523/en/Quanterix%E2%80%99-Simoa-Technology-Powers-New-Insights-COVID-19) [![Logo_Takeda.svg-1](https://info.wolfgreenfield.com/hs-fs/hubfs/Logo_Takeda.svg-1.png?width=488&name=Logo_Takeda.svg-1.png) ](https://info.wolfgreenfield.com/covid-19-resource-center#team-member34) ![Logo_Takeda.svg-1](https://info.wolfgreenfield.com/hs-fs/hubfs/Logo_Takeda.svg-1.png?width=488&height=164&name=Logo_Takeda.svg-1.png) **Takeda** donated more than $6 million to fight coronavirus.  [Read More](https://www.bostonglobe.com/2020/03/25/business/takeda-donates-more-than-6-million-fight-coronavirus/) They are also collaborating with other companies to accelerate development of potential COVID-19 Hyperimmune Therapy.  [Read More](https://www.biospace.com/article/releases/global-plasma-leaders-collaborate-to-accelerate-development-of-potential-covid-19-hyperimmune-therapy-/) [![translate bio smaller](https://info.wolfgreenfield.com/hs-fs/hubfs/translate%20bio%20smaller.png?width=122&name=translate%20bio%20smaller.png) ](https://info.wolfgreenfield.com/covid-19-resource-center#team-member35) ![translate bio smaller](https://info.wolfgreenfield.com/hs-fs/hubfs/translate%20bio%20smaller.png?width=122&height=120&name=translate%20bio%20smaller.png) **Translate Bio** and Sanofi Pasteur are collaborating to develop a novel mRNA vaccine candidate against COVID-19.  [Read More](https://www.globenewswire.com/news-release/2020/03/27/2007405/0/en/Sanofi-Pasteur-and-Translate-Bio-to-Collaborate-to-Develop-a-Novel-mRNA-Vaccine-Candidate-Against-COVID-19.html)     [![Oyer, Tim small-1](https://info.wolfgreenfield.com/hs-fs/hubfs/Oyer%2c%20Tim%20small-1.jpg?width=220&name=Oyer%2c%20Tim%20small-1.jpg "Oyer, Tim small-1")](https://www.wolfgreenfield.com/professionals/o/oyer-timothy-j) ## [Tim Oyer](https://www.wolfgreenfield.com/professionals/o/oyer-timothy-j) President and Managing Partner #### A Message from our President and Managing Partner The sweeping impacts of COVID-19 are immeasurable and, at times, defeating. We have taken solace in the fact that people across the globe are coming together (while remaining socially distant) to help address and overcome this pandemic. As a firm, we feel incredibly fortunate to support clients across industries and geographies–some of whom were part of the earliest adopters in shifting gears and focusing on efforts to combat coronavirus. During this unprecedented time, we want you to know that we are still here to help. We vow to provide you with the high level of service you deserve, and we will do everything we can to have a positive impact on you. We want our clients to be able to focus on their families and know their IP interests are safe with us. Our sincere thoughts are with those impacted by the virus. # Our Team ##### If you have questions about how COVID-19 may impact your IP strategy, feel free to contact us. ![Baker, Hunter small-1](https://info.wolfgreenfield.com/hs-fs/hubfs/Baker%2c%20Hunter%20small-1.jpg?width=220&height=220&name=Baker%2c%20Hunter%20small-1.jpg) #### [Hunter Baker](https://www.wolfgreenfield.com/professionals/b/baker-c-hunter) Pharmaceutical Chair ![Corbett, Greg small](https://info.wolfgreenfield.com/hs-fs/hubfs/Corbett%2c%20Greg%20small.jpg?width=220&height=220&name=Corbett%2c%20Greg%20small.jpg) #### [Greg Corbett](https://www.wolfgreenfield.com/professionals/w/walat-robert-hhttps://www.wolfgreenfield.com/professionals/c/corbett-gregory-f) Litigation Chair ![Ferraro_Neil_small](https://info.wolfgreenfield.com/hs-fs/hubfs/Ferraro_Neil_small.jpg?width=220&height=220&name=Ferraro_Neil_small.jpg) #### [Neil Ferraro](https://www.wolfgreenfield.com/professionals/f/ferraro-neil-p) Mechanical Technologies Chair ![Giunta, Rich small](https://info.wolfgreenfield.com/hs-fs/hubfs/Giunta%2c%20Rich%20small.jpg?width=221&height=220&name=Giunta%2c%20Rich%20small.jpg) #### [Rich Giunta](https://www.wolfgreenfield.com/professionals/g/giunta-richard-f) Post-Grant Chair ![Lockhart, Helen small](https://info.wolfgreenfield.com/hs-fs/hubfs/Lockhart%2c%20Helen%20small.jpg?width=220&height=220&name=Lockhart%2c%20Helen%20small.jpg) #### [Helen Lockhart](https://www.wolfgreenfield.com/professionals/l/lockhart-helen-c) Biotechnology Chair ![Pritzker, Randy small retake](https://info.wolfgreenfield.com/hs-fs/hubfs/Pritzker%2c%20Randy%20small%20retake.jpg?width=220&height=220&name=Pritzker%2c%20Randy%20small%20retake.jpg) #### [Randy Pritzker](https://www.wolfgreenfield.com/professionals/p/pritzker-randy-j) Electrical Computer Technologies Chair ![Walat, Rob small](https://info.wolfgreenfield.com/hs-fs/hubfs/Walat%2c%20Rob%20small.jpg?width=220&height=220&name=Walat%2c%20Rob%20small.jpg) #### [Rob Walat](https://www.wolfgreenfield.com/professionals/w/walat-robert-h) Chemical & Material Technologies Chair ![Wolf, Doug small](https://info.wolfgreenfield.com/hs-fs/hubfs/Wolf%2c%20Doug%20small.jpg?width=220&height=220&name=Wolf%2c%20Doug%20small.jpg) #### [Doug Wolf](https://www.wolfgreenfield.com/professionals/w/wolf-douglas-r) Trademark & Copyright Chair [Meet the full Team](https://wolfgreenfield.com/professionals) # Additional Resources ##### Here are links to some resources we are regularly utilizing for intellectual property, business and health updates. This aggregated list is being frequently updated with more resources you may find helpful. ** ![USPTO3](https://info.wolfgreenfield.com/hs-fs/hubfs/USPTO3.png?width=1024&height=512&name=USPTO3.png) ##### [United States Patent and Trademark Office](https://www.uspto.gov/coronavirus) ** ![CDC2](https://info.wolfgreenfield.com/hs-fs/hubfs/CDC2.png?width=1024&height=512&name=CDC2.png) ##### [Centers for Disease Control and Prevention](https://www.cdc.gov/coronavirus/2019-ncov/community/organizations/businesses-employers.html) ** ![ITC2](https://info.wolfgreenfield.com/hs-fs/hubfs/ITC2.png?width=1024&height=512&name=ITC2.png) ##### [US International Trade Commission](https://www.usitc.gov/press_room/featured_news/usitc_response_covid_19.htm)     ** ![WHO](https://info.wolfgreenfield.com/hs-fs/hubfs/WHO.png?width=1024&height=512&name=WHO.png) ##### [World Health Organization](https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen) ** ![WIPO2](https://info.wolfgreenfield.com/hs-fs/hubfs/WIPO2.png?width=1024&height=512&name=WIPO2.png) ##### [World Intellectual Property Organization](https://www.wipo.int/portal/en/news/2020/article_0015.html) ** ![NGA](https://info.wolfgreenfield.com/hs-fs/hubfs/NGA.png?width=1024&height=512&name=NGA.png) ##### [National Governors Association](https://www.nga.org/coronavirus/#actions) Wolf, Greenfield & Sacks, P.C.,© 2021 Wolf, Greenfield & Sacks, P.C. All Rights Reserved. 600 Atlantic Avenue, Boston, MA 02210, +1 617-646-8000  605 Third Avenue, New York, NY 10158, +1 212-697-7890 [WolfGreenfield.com](https://wolfgreenfield.com/)